ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), a biopharmaceutical company, focuses on developing and commercializing a varied, risk-sensitive portfolio of in-licensed cancer drugs that address unmet medical needs. The company’s business strategy is to utilize new insights from molecular and cancer biology to understand the effectiveness and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment. For further information, visit the Company’s web site at www.ziopharm.com.